Sarah Moore

PhD candidate @velasquez_lab @stjudegraduate

[Sarah Moore @saremoore]

@SherifAbdlhamed Amazing!! Congrats ☺️

[St. Jude Graduate School of Biomedical Sciences @stjudegraduate]

The only known cure for sickle cell disease is bone marrow transplantation. In 1983, St. Jude doctors were the first to make that discovery. Join the next generation of investigators who will discover cures and advance research. https://t.co/ZbUyIBsHH3

[Sarah Moore @saremoore]

Last day of #ASGCT22! Don’t forget to tune into @Jorge88382322’s talk “Dysfunctional Immune Synapses Restrain Anti DIPG Activity of CAR T Cells” in person or virtually at 11:30 EST room 206 @StJudeResearch @ASGCTherapy #CARTcells #DIPG

[Sarah Moore @saremoore]

Lizzie Wickman did a fantastic job presenting her talk “Targeting the C Domain of Tenascin C with CAR T Cells for the Immunotherapy of Pediatric Brain and Solid Tumor” @stjudegraduate @StJudeResearch #ASGCT22 @ASGCTherapy

[Sarah Moore @saremoore]

Pumped to support my fellow @stjudegraduate student’s Lizzie Wickman at the Cell-Based Cancer Immunotherapy II session Salon G at 3:45 and @itsalexbeckett at Poster 233 5:30-6:30 #teamCART #immunotherapy #ASGCT2022 @StJudeResearch @ASGCTherapy

[Sarah Moore @saremoore]

Starting off the morning of day 3 #ASGCT2022 right - by listening to groundbreaking research in Late-Breaking Abstracts II with coffee in hand @Matthew_R_Bell @ASGCTherapy

[St. Jude Research @StJudeResearch]

Join the CAR T-cell Efficacy session at #ASGCT22 to hear @BrookePrinzing present “High-affinity PD1-CD28 Chimeric Switch Receptors Enhance Costimulatory Signaling and Improve TCR and CAR T-cell Antitumor Activity” at 5 pm ET, May 17 in Room 102. https://t.co/TcJdblTIu1

[St. Jude Research @StJudeResearch]

.@Matthew_R_Bell will present “Leucine Zipper-based Cytokine Receptors Augments CAR T-cell Immunotherapy for Solid Tumors” at 3:45 pm ET Tues, May 17, during the CAR T-cell Efficacy session in Room 102. https://t.co/f3E7OKCczM #ASGCT22

[Sarah Moore @saremoore]

Zippity-receptor-doo-dah! Can’t wait for @Matthew_R_Bell’s first presentation and to ~switch~ it up with @BrookePrinzing’s new high-affinity receptor at the Enhancing CAR-T Cell Efficacy #ASGCT22 Room 102A/B at 3:45 @stjudegraduate @StJudeResearch @ASGCTherapy

[Sarah Moore @saremoore]

Thank you Nathan Schloemer @childrenswi @MedicalCollege for a great talk at #ASGCT22 expanding my knowledge of NK cell biology and the advancements of NK cells for cancer therapy! #NKCells #ASGCTherapy

[St. Jude Research @StJudeResearch]

Watch “Naturally Occurring CD7- T-cells Mark a Functional Effector and Persistent CAR T-cell Population,” presented by Dr. Jacquelyn Zoine Monday, May 16, at 4:30 pm ET in the CAR T-cells and Beyond session in Room 102 at #ASGCT22. https://t.co/pvNEuXBEBQ @JTZoine

[St. Jude Research @StJudeResearch]

Watch Dr. Jacquelyn Zoine’s talk, “Peptide-scFv Bispecific CAR T-cells Targeting Acute Myeloid Leukemia,” today at 5 pm ET in the CAR T-cells and Beyond session in Room 102 at #ASGCT22. https://t.co/SZIJ8nfpQx @JTZoine

[Alex Beckett, PhD @AlexBeckettPhD]

Exciting new research coming out of the @NaldiniLab! Great talk by @f_rossari @ASGCTherapy #ASGCT2022

[Alex Beckett, PhD @AlexBeckettPhD]

Day 1 at first #inperson conference #ASGCT2022 was a success! @ASGCTherapy @StJudeResearch @stjudegraduate check out my poster on #wednesday #CARTcell #Immunotherapy #AcademicChatter #phdchat

[Sarah Moore @saremoore]

Fascinating research @f_rossari @NaldiniLab utilizing #genetherapy to reprogram the harsh GBM TME, thus enhancing #CARTcell efficacy @ASGCTherapy #ASGCT22

[Sarah Moore @saremoore]

Great research, exciting talks, and my favorite post doc @JTZoine representing @velasquez_lab at #ASGCT22 for my first #inperson conference! #teamCART #Immunotherapy #genetherapy @stjudegraduate @StJudeResearch @ASGCTherapy

[Sarah Moore @saremoore]

So excited to kick off the #ASGCT22 conference with the Pre-Meeting Immune Effector Cell Therapies Workshop! @ASGCTherapy @GiedreKrenciute

[St. Jude Graduate School of Biomedical Sciences @stjudegraduate]

PhD student @Matthew_R_Bell will participate in the “CAR T cell Efficacy” session at @ASGCTherapy. May 17 he will discuss his work engineering a more effective CAR T cell immunotherapy for solid tumors. Learn more. https://t.co/riqG36O8dA #ASGCT22

[St. Jude Graduate School of Biomedical Sciences @stjudegraduate]

PhD candidate Elizabeth Wickman will present her work at @ASGCTherapy May 18. She will discuss a potential target for CAR T cells in the immunotherapy of pediatric brain and solid tumors. Learn more. https://t.co/riqG36O8dA #ASGCT22

[Sarah Moore @saremoore]

@TiffanyYee12 Yes!! You go girl 🥰